The safety and efficacy of guselkumab for the treatment of moderate to severely active ulcerative colitis. Khanna R. Gastroenterology 2025 Jan 31:S0016-5085(25)00333.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Khanna R. The safety and efficacy of guselkumab for the treatment of moderate to severely active ulcerative colitis. Gastroenterology 2025 Jan 31:S0016-5085(25)00333.
PMID: 39894287